AKT1 and breast carcinoma: Moreover, miR-21's targeting of PIK3R1 inhibits tumor cell migration and invasion by reducing PI3K/AKT signaling, reversing epithelial-to-mesenchymal transition, and predicting clinical outcomes in breast cancer 15.